galleon pharmaceuticals

Worldwide there are hundreds of millions of patients with breathing control disorders associated with common conditions such as sleep apnea, surgical anesthesia, lung disease, heart disease, diabetes and pain medications.

Newsroom

1-Dec-2011 Galleon Pharmaceuticals Names Lynne Brookes Senior Vice President and Chief Business Officer
1-Nov-2011 Galleon Pharmaceuticals Names Two Executives to Senior Drug Discovery and Clinical Development Positions
26-Oct-2011 Thomas Dietz, Ph.D, Elected Chairman of Galleon Pharmaceuticals
1-May-2006 Galleon Pharmaceuticals is named SR ONE Biotech Company of the Year for Innovative Approach in Developing Sleep Apnea Medicines
  • Scientific Publiation 01: Lorem ipsum dolor sit amet, typicus refero, erat nisl vulpes.
  • Scientific Publiation 01: Lorem ipsum dolor sit amet, typicus refero, erat nisl vulpes.
  • Scientific Publiation 01: Lorem ipsum dolor sit amet, typicus refero, erat nisl vulpes.
  • Scientific Publiation 01: Lorem ipsum dolor sit amet, typicus refero, erat nisl vulpes.
  • Scientific Publiation 01: Lorem ipsum dolor sit amet, typicus refero, erat nisl vulpes.
  • Scientific Publiation 01: Lorem ipsum dolor sit amet, typicus refero, erat nisl vulpes.